Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RKLB vs MRNA✓SelectedUSD · MRNARKLB vs MRNA performance historyLatest closeAs of-10.92%11/20
Stock and ETF performance explorer

RKLB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+953.8%
MRNA return
+153.9%
Excess return
+799.9%
Maximum drawdown
-69.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-10.9%-2.2%-8.8%-10.7%
7D-26.2%-12.7%-13.5%-25.3%
30D-15.4%-20.7%+5.3%-13.7%
3M-37.7%+46.3%-84.0%-39.9%
6M-66.2%+305.2%-371.4%-74.3%
YTD-34.9%+561.2%-596.1%-57.0%
1Y+15.0%+772.1%-757.0%-29.0%
3Y+953.8%+147.0%+806.9%+642.4%
All+953.8%+153.9%+799.9%+642.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling